These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

366 related articles for article (PubMed ID: 35042840)

  • 1. Role of NLRP3 Inflammasome in Myocardial Ischemia-Reperfusion Injury and Ventricular Remodeling.
    Shen S; Wang Z; Sun H; Ma L
    Med Sci Monit; 2022 Jan; 28():e934255. PubMed ID: 35042840
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cathelicidin aggravates myocardial ischemia/reperfusion injury via activating TLR4 signaling and P2X
    Wu Y; Zhang Y; Zhang J; Zhai T; Hu J; Luo H; Zhou H; Zhang Q; Zhou Z; Liu F
    J Mol Cell Cardiol; 2020 Feb; 139():75-86. PubMed ID: 31982429
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cinnamic acid preserves against myocardial ischemia/reperfusion injury via suppression of NLRP3/Caspase-1/GSDMD signaling pathway.
    Luan F; Rao Z; Peng L; Lei Z; Zeng J; Peng X; Yang R; Liu R; Zeng N
    Phytomedicine; 2022 Jun; 100():154047. PubMed ID: 35320770
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardioprotective effect of cinnamaldehyde pretreatment on ischemia/ reperfusion injury via inhibiting NLRP3 inflammasome activation and gasdermin D mediated cardiomyocyte pyroptosis.
    Luan F; Lei Z; Peng X; Chen L; Peng L; Liu Y; Rao Z; Yang R; Zeng N
    Chem Biol Interact; 2022 Dec; 368():110245. PubMed ID: 36341777
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cell-Specific Roles of NLRP3 Inflammasome in Myocardial Infarction.
    Takahashi M
    J Cardiovasc Pharmacol; 2019 Sep; 74(3):188-193. PubMed ID: 31356542
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Piperazine ferulate protects against cardiac ischemia/reperfusion injury in rat via the suppression of NLRP3 inflammasome activation and pyroptosis.
    Lei Z; Luan F; Zhang X; Peng L; Li B; Peng X; Liu Y; Liu R; Zeng N
    Eur J Pharmacol; 2022 Apr; 920():174856. PubMed ID: 35219728
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of NLRP3 Inflammasome in Cardiac Inflammation and Remodeling after Myocardial Infarction.
    Takahashi M
    Biol Pharm Bull; 2019; 42(4):518-523. PubMed ID: 30930410
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Kanglexin, a novel anthraquinone compound, protects against myocardial ischemic injury in mice by suppressing NLRP3 and pyroptosis.
    Bian Y; Li X; Pang P; Hu XL; Yu ST; Liu YN; Li X; Wang N; Wang JH; Xiao W; Du WJ; Yang BF
    Acta Pharmacol Sin; 2020 Mar; 41(3):319-326. PubMed ID: 31645662
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NLRP3 Inflammasome Activation-Mediated Pyroptosis Aggravates Myocardial Ischemia/Reperfusion Injury in Diabetic Rats.
    Qiu Z; Lei S; Zhao B; Wu Y; Su W; Liu M; Meng Q; Zhou B; Leng Y; Xia ZY
    Oxid Med Cell Longev; 2017; 2017():9743280. PubMed ID: 29062465
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Beta-Asarone Alleviates Myocardial Ischemia-Reperfusion Injury by Inhibiting Inflammatory Response and NLRP3 Inflammasome Mediated Pyroptosis.
    Xiao B; Huang X; Wang Q; Wu Y
    Biol Pharm Bull; 2020 Jul; 43(7):1046-1051. PubMed ID: 32321872
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardioprotective activity of ethyl acetate extract of Cinnamomi Ramulus against myocardial ischemia/reperfusion injury in rats via inhibiting NLRP3 inflammasome activation and pyroptosis.
    Peng L; Lei Z; Rao Z; Yang R; Zheng L; Fan Y; Luan F; Zeng N
    Phytomedicine; 2021 Dec; 93():153798. PubMed ID: 34673348
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TRIM16 exerts protective function on myocardial ischemia/reperfusion injury through reducing pyroptosis and inflammation via NLRP3 signaling.
    Shi M; Su F; Dong Z; Shi Y; Tian X; Cui Z; Li J
    Biochem Biophys Res Commun; 2022 Dec; 632():122-128. PubMed ID: 36208489
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metformin protects against myocardial ischemia-reperfusion injury and cell pyroptosis via AMPK/NLRP3 inflammasome pathway.
    Zhang J; Huang L; Shi X; Yang L; Hua F; Ma J; Zhu W; Liu X; Xuan R; Shen Y; Liu J; Lai X; Yu P
    Aging (Albany NY); 2020 Nov; 12(23):24270-24287. PubMed ID: 33232283
    [TBL] [Abstract][Full Text] [Related]  

  • 14. M2 macrophage-derived exosomes carry microRNA-148a to alleviate myocardial ischemia/reperfusion injury via inhibiting TXNIP and the TLR4/NF-κB/NLRP3 inflammasome signaling pathway.
    Dai Y; Wang S; Chang S; Ren D; Shali S; Li C; Yang H; Huang Z; Ge J
    J Mol Cell Cardiol; 2020 May; 142():65-79. PubMed ID: 32087217
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Naoxintong attenuates Ischaemia/reperfusion Injury through inhibiting NLRP3 inflammasome activation.
    Wang Y; Yan X; Mi S; Li Z; Wang Y; Zhu H; Sun X; Zhao B; Zhao C; Zou Y; Hu K; Ding X; Sun A; Ge J
    J Cell Mol Med; 2017 Jan; 21(1):4-12. PubMed ID: 27785882
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sacubitril/valsartan (LCZ696) reduces myocardial injury following myocardial infarction by inhibiting NLRP3‑induced pyroptosis via the TAK1/JNK signaling pathway.
    Shen J; Fan Z; Sun G; Qi G
    Mol Med Rep; 2021 Sep; 24(3):. PubMed ID: 34296299
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The NLRP3 inflammasome: Multiple activation pathways and its role in primary cells during ventricular remodeling.
    Yan Z; Qi Z; Yang X; Ji N; Wang Y; Shi Q; Li M; Zhang J; Zhu Y
    J Cell Physiol; 2021 Aug; 236(8):5547-5563. PubMed ID: 33469931
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TXNIP mediates NLRP3 inflammasome activation in cardiac microvascular endothelial cells as a novel mechanism in myocardial ischemia/reperfusion injury.
    Liu Y; Lian K; Zhang L; Wang R; Yi F; Gao C; Xin C; Zhu D; Li Y; Yan W; Xiong L; Gao E; Wang H; Tao L
    Basic Res Cardiol; 2014; 109(5):415. PubMed ID: 25015733
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The NLRP3 inflammasome is up-regulated in cardiac fibroblasts and mediates myocardial ischaemia-reperfusion injury.
    Sandanger Ø; Ranheim T; Vinge LE; Bliksøen M; Alfsnes K; Finsen AV; Dahl CP; Askevold ET; Florholmen G; Christensen G; Fitzgerald KA; Lien E; Valen G; Espevik T; Aukrust P; Yndestad A
    Cardiovasc Res; 2013 Jul; 99(1):164-74. PubMed ID: 23580606
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lipopolysaccharide (LPS) Aggravates High Glucose- and Hypoxia/Reoxygenation-Induced Injury through Activating ROS-Dependent NLRP3 Inflammasome-Mediated Pyroptosis in H9C2 Cardiomyocytes.
    Qiu Z; He Y; Ming H; Lei S; Leng Y; Xia ZY
    J Diabetes Res; 2019; 2019():8151836. PubMed ID: 30911553
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.